RAPT Therapeutics, Inc. (RAPT) Ownership

$1.70

south_east -$0.12 (-6.35%)
Day's range
$1.69
Day's range
$1.94

RAPT Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2024 5.24 M $10.52 M   0.00% 13.46%
VANGUARD GROUP INC 11/13/2024 3.16 M $6.34 M   1.54% 8.11%
COLUMN GROUP LLC 11/14/2024 2.68 M $5.39 M   0.00% 6.89%
BLACKROCK FUNDING, INC. /DE 11/13/2024 2.50 M $5.02 M   100.00% 6.42%
KINGDON CAPITAL MANAGEMENT, L.L.C. 11/14/2024 1.73 M $3.47 M   0.00% 4.43%
D. E. SHAW & CO., INC. 11/14/2024 1.05 M $2.11 M   15.51% 2.69%
MILLENNIUM MANAGEMENT LLC 11/14/2024 959,965 $1.93 M   -6.26% 2.47%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 842,157 $1.69 M   80.26% 2.16%
TWO SIGMA ADVISERS, LP 11/14/2024 705,000 $1.42 M   0.95% 1.81%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 683,179 $1.37 M   -0.22% 1.76%
STATE STREET CORP 11/14/2024 679,508 $1.37 M   1.15% 1.75%
EUCLIDEAN CAPITAL LLC 11/14/2024 657,899 $1.32 M   0.00% 1.69%
ALPHABET INC. 11/08/2024 540,270 $1.09 M   0.00% 1.39%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 525,221 $1.06 M   -25.74% 1.35%
TWO SIGMA INVESTMENTS, LP 11/14/2024 520,422 $1.05 M   -15.01% 1.34%
PALE FIRE CAPITAL SE 11/12/2024 510,724 $1.03 M   3,078.12% 1.31%
REDMILE GROUP, LLC 11/14/2024 504,532 $1.01 M   -5.99% 1.30%
CORMORANT ASSET MANAGEMENT, LP 11/14/2024 496,750 $998,468   0.00% 1.28%
GOLDMAN SACHS GROUP INC 11/14/2024 397,753 $799,484   6.41% 1.02%
SIO CAPITAL MANAGEMENT, LLC 11/14/2024 315,000 $633,150   0.00% 0.81%
MORGAN STANLEY 11/14/2024 307,236 $617,544   -73.94% 0.79%
BANK OF AMERICA CORP /DE/ 11/14/2024 299,531 $602,058   230.40% 0.77%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 294,600 $592,146   44.48% 0.76%
OCTAGON CAPITAL ADVISORS LP 11/14/2024 292,000 $586,920   0.00% 0.75%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 254,054 $510,533   -23.45% 0.65%
WOODLINE PARTNERS LP 11/14/2024 236,990 $476,350   42.78% 0.61%
LOS ANGELES CAPITAL MANAGEMENT LLC 11/04/2024 201,439 $404,892   138.15% 0.52%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 175,776 $355,000   -15.69% 0.45%
IKARIAN CAPITAL, LLC 11/14/2024 154,625 $310,796   0.00% 0.40%
WALLEYE CAPITAL LLC 11/14/2024 101,163 $203,338   -12.64% 0.26%
BANK OF NEW YORK MELLON CORP 11/12/2024 90,209 $181,320   -21.28% 0.23%
EXCHANGE TRADED CONCEPTS, LLC 10/10/2024 89,076 $179,043   244.71% 0.23%
NOMURA HOLDINGS INC 11/14/2024 84,184 $169,210   100.00% 0.22%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 77,709 $156,195   0.00% 0.20%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2024 75,000 $150,750   100.00% 0.19%
CAPTION MANAGEMENT, LLC 11/14/2024 71,449 $143,612   -34.90% 0.18%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 70,946 $142,601   -65.91% 0.18%
JANE STREET GROUP, LLC 11/15/2024 66,515 $133,696   -66.91% 0.17%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2024 55,520 $111,595   -81.20% 0.14%
ALLIANCEBERNSTEIN L.P. 11/14/2024 50,710 $101,927   0.00% 0.13%
HENNION & WALSH ASSET MANAGEMENT, INC. 10/22/2024 47,927 $96,333   -1.23% 0.12%
ALGERT GLOBAL LLC 11/12/2024 47,483 $95,000   0.00% 0.12%
RHUMBLINE ADVISERS 11/12/2024 46,193 $92,835   -0.69% 0.12%
JASPER RIDGE PARTNERS, L.P. 11/14/2024 45,650 $91,756   0.00% 0.12%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2024 45,050 $90,551   0.00% 0.12%
BARCLAYS PLC 11/19/2024 39,729 $79,000   277.15% 0.10%
TREXQUANT INVESTMENT LP 11/12/2024 37,955 $76,290   -73.71% 0.10%
PDT PARTNERS, LLC 11/14/2024 36,998 $74,366   -62.17% 0.10%
UBS GROUP AG 11/14/2024 28,846 $57,980   0.90% 0.07%
CITADEL ADVISORS LLC 11/14/2024 25,600 $51,456   -67.47% 0.07%

RAPT Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of RAPT shares?

During the previous two years, 126 institutional investors and hedge funds held shares of RAPT Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 5.24 M

VANGUARD GROUP INC: 3.16 M

Column Group LLC: 2.68 M

BlackRock Funding, Inc. /DE: 2.5 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 1.73 M

D. E. Shaw & Co., Inc.: 1.05 M

What percentage of RAPT Therapeutics, Inc. stock is owned by institutional investors?

76.60% of RAPT Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at RAPT ?

Institutional investors have bought a total of 39.51 M shares in the last 24 months. This purchase volume represents approximately $67.17 M in transactions.